meglumine has been researched along with Biliary Tract Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billington, PD; Lapsia, S; Prescott, RJ | 1 |
| Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
1 trial(s) available for meglumine and Biliary Tract Cancer
| Article | Year |
|---|---|
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
1 other study(ies) available for meglumine and Biliary Tract Cancer
| Article | Year |
|---|---|
Diagnosis of a biliary cystadenoma demonstrating communication with the biliary system by MRI using a hepatocyte-specific contrast agent.
Topics: Adult; Biliary Tract Neoplasms; Contrast Media; Cystadenoma; Female; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2012 |